SEC Form 4 · accession 0001127602-16-061166
HAEMONETICS CORP · HAE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ronald G Gelbman
Director
Period of report
Jul 29, 2016
Accepted (ET)
Aug 25, 2016 · 5:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000313143
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 29, 2016 | F | 11,614 | $30.09 | D | 55,371 | D | |
| Common Stock | Jul 29, 2016 | M | 11,758 | $29.72 | A | 66,985 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified Stock Option (Right to Buy)F1 | $29.72 | Jul 29, 2016 | M | 11,758 | D | Jul 30, 2010 | Jul 30, 2016 | Common Stock | 11,758 | 0 | D |
Explanation of responses
- F1Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant.